title: The M33 G protein-coupled receptor encoded by murine cytomegalovirus is dispensable for hematogenous dissemination but is required for growth within the salivary gland.
abstract: Human cytomegalovirus (HCMV) is a pathogen found worldwide and is a serious threat to immunocompromised individuals and developing fetuses. Due to the species specificity of cytomegaloviruses, murine cytomegalovirus (MCMV) has been used as a model for in vivo studies of HCMV pathogenesis. The MCMV genome, like the genomes of other beta- and gammaherpesviruses, encodes G protein-coupled receptors (GPCRs) that modulate host signaling pathways presumably to facilitate viral replication and dissemination. Among these viral receptors, the M33 GPCR carried by MCMV is an activator of CREB, NF-κB, and phospholipase C-β signaling pathways and has been implicated in aspects of pathogenesis in vivo, including persistence in the salivary glands of BALB/c mice. In this study, we used immunocompetent nonobese diabetic (NOD) and immunocompromised NOD-scid-gamma (NSG) mice to further investigate the salivary gland defect exhibited by M33 deficiency. Interestingly, we demonstrate that virus with an M33 deletion (ΔM33) can replicate in the salivary gland of immunocompromised animals, albeit with a 400-fold growth defect compared with the growth of wild-type virus. Moreover, we determined that M33 does not have a role in cell-associated hematogenous dissemination but is required for viral amplification once the virus reaches the salivary gland. We conclude that the reduced replicative capacity of the ΔM33 virus is due to a specific defect occurring within the localized environment of the salivary gland. Importantly, since the salivary gland represents a site essential for persistence and horizontal transmission, an understanding of the mechanisms of viral replication within this site could lead to the generation of novel therapeutics useful for the prevention of HCMV spread. Importance: Human cytomegalovirus infects the majority of the American people and can reside silently in infected individuals for the duration of their lives. Under a number of circumstances, the virus can reactivate, leading to a variety of diseases in both adults and developing babies, and therefore, identifying the function of viral proteins is essential to understand how the virus spreads and causes disease. We aim to utilize animal models to study the function of an important class of viral proteins termed G protein-coupled receptors with the ultimate goal of developing inhibitors to these proteins that could one day be used to prevent viral spread.
authors.affiliation: Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
authors.forename: Fabiola M
authors.initials: FM
authors.lastname: Bittencourt
authors.affiliation: Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
authors.forename: Shu-En
authors.initials: SE
authors.lastname: Wu
authors.affiliation: Perinatal Institute, Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
authors.forename: James P
authors.initials: JP
authors.lastname: Bridges
authors.affiliation: Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA william.miller@uc.edu.
authors.forename: William E
authors.initials: WE
authors.lastname: Miller
mesh_terms: D000818:Animals; D002460:Cell Line; D003587:Cytomegalovirus / Q000235:genetics / Q000254:growth & development*; D051379:Mice; D008807:Mice, Inbred BALB C; D043562:Receptors, G-Protein-Coupled / Q000235:genetics* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012469:Salivary Glands / Q000821:virology*
chemical_list: D043562:Receptors, G-Protein-Coupled
references.citation: Med Microbiol Immunol. 2008 Jun;197(2):205-13
references.pmid: 18259775
references.citation: Rev Med Virol. 2010 Jul;20(4):202-13
references.pmid: 20564615
references.citation: Med Microbiol Immunol. 2012 Nov;201(4):475-86
references.pmid: 22965170
references.citation: Biomed Res Int. 2013;2013:815895
references.pmid: 23841093
references.citation: J Exp Med. 2007 May 14;204(5):1217-25
references.pmid: 17485516
references.citation: Am J Pathol. 1972 Jul;68(1):183-202
references.pmid: 4342992
references.citation: J Virol. 2013 Apr;87(7):4112-7
references.pmid: 23345521
references.citation: J Virol. 2002 Aug;76(16):8161-8
references.pmid: 12134021
references.citation: Nat Rev Immunol. 2012 Nov;12(11):786-98
references.pmid: 23059428
references.citation: Cell Host Microbe. 2010 Apr 22;7(4):302-313
references.pmid: 20413098
references.citation: J Virol. 1994 Oct;68(10):6305-11
references.pmid: 8083970
references.citation: Nature. 2011 Nov 30;481(7379):81-4
references.pmid: 22139420
references.citation: PLoS Pathog. 2011 Aug;7(8):e1002214
references.pmid: 21901102
references.citation: Methods Mol Biol. 2009;530:365-78
references.pmid: 19266338
references.citation: Rev Med Virol. 2007 Sep-Oct;17(5):355-63
references.pmid: 17542052
references.citation: Cell Host Microbe. 2008 Apr 17;3(4):263-72
references.pmid: 18407069
references.citation: PLoS Pathog. 2011 Nov;7(11):e1002366
references.pmid: 22114552
references.citation: PLoS Pathog. 2013 Feb;9(2):e1003192
references.pmid: 23468630
references.citation: Nutr Rev. 2004 Jun;62(6 Pt 1):243-6
references.pmid: 15291397
references.citation: Virology. 1991 Jul;183(1):181-94
references.pmid: 1711256
references.citation: J Virol. 1989 Jun;63(6):2667-73
references.pmid: 2542580
references.citation: EMBO J. 1998 Aug 3;17(15):4304-12
references.pmid: 9687499
references.citation: Infect Immun. 1983 Aug;41(2):841-3
references.pmid: 6307886
references.citation: J Immunol. 2005 May 15;174(10):6477-89
references.pmid: 15879151
references.citation: J Virol. 1997 Feb;71(2):1521-9
references.pmid: 8995678
references.citation: Transpl Infect Dis. 2001;3 Suppl 2:1-5
references.pmid: 11926743
references.citation: J Virol. 2009 Aug;83(16):8141-52
references.pmid: 19494016
references.citation: J Virol. 1990 Nov;64(11):5457-64
references.pmid: 1976821
references.citation: J Virol. 1999 Aug;73(8):6800-9
references.pmid: 10400778
references.citation: Arch Virol. 2000;145(12):2601-18
references.pmid: 11205107
references.citation: Eur J Cell Biol. 2012 Jan;91(1):70-7
references.pmid: 21492952
references.citation: J Virol. 2012 Dec;86(23):12879-90
references.pmid: 22993151
references.citation: J Virol. 1994 Dec;68(12):7717-27
references.pmid: 7966561
references.citation: J Virol. 2011 Jun;85(12):6091-5
references.pmid: 21490099
references.citation: Immunol Cell Biol. 2007 Jan;85(1):46-54
references.pmid: 17146464
references.citation: Immunity. 1995 Mar;2(3):223-38
references.pmid: 7697543
references.citation: Microbes Infect. 2003 Nov;5(13):1263-77
references.pmid: 14623023
references.citation: J Biol Chem. 2006 Dec 29;281(52):39796-805
references.pmid: 17088245
references.citation: J Virol. 2005 Aug;79(16):10788-95
references.pmid: 16051870
references.citation: J Virol. 2009 Aug;83(15):7590-601
references.pmid: 19439478
references.citation: Annu Rev Food Sci Technol. 2013;4:267-76
references.pmid: 23464573
references.citation: J Virol. 2001 Jul;75(14):6292-302
references.pmid: 11413295
references.citation: J Virol. 2008 Feb;82(4):1884-98
references.pmid: 18057236
references.citation: J Clin Virol. 2008 Feb;41(2):57-62
references.pmid: 17959414
references.citation: Clin Microbiol Rev. 2013 Jan;26(1):86-102
references.pmid: 23297260
references.citation: Drugs. 2010 May 28;70(8):965-81
references.pmid: 20481654
references.citation: Methods Mol Biol. 2014;1119:289-310
references.pmid: 24639229
references.citation: Cell Host Microbe. 2010 Sep 16;8(3):284-91
references.pmid: 20833379
references.citation: J Virol. 1987 Oct;61(10):3102-8
references.pmid: 3041033
references.citation: J Gen Virol. 2009 Jan;90(Pt 1):33-43
references.pmid: 19088270
references.citation: J Exp Med. 1989 Apr 1;169(4):1199-212
references.pmid: 2564415